Clinical Trial Update: Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib for gastrointestinal stromal tumors has completed, reporting efficacy results from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: Centre Leon Berard | Conditions: GIST | Phase 2 | Status: COMPLETED